NADAC acquisition cost data for ANASPAZ 0.125 MG TABLET ODT. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00225029515 | $0.1377 | 2022-12-21 | Rx |
| 00225029520 | $0.1377 | 2022-12-21 | Rx |
| 00225029515 | $0.1377 | 2022-12-21 | Rx |
| 00225029520 | $0.1377 | 2022-12-21 | Rx |
Generic: Hyoscyamine Sulfate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $4.8K | 327 | 178 | $0.2264 |
| 2020 | $2.8K | 162 | 75 | $0.2582 |
| 2021 | $3.4K | 175 | 62 | $0.2741 |
| 2022 | $3.9K | 159 | 49 | $0.2734 |
| 2023 | $536.82 | 29 | 14 | $0.2789 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Oklahoma | $259.35 | 16 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.